Intel Corp Senti Biosciences, Inc. Transaction History

Intel Corp

  • $117 Million
  • Q3 2024

A detailed history of Intel Corp transactions in Senti Biosciences, Inc. stock. As of the latest transaction made, Intel Corp holds 48,048 shares of SNTI stock, worth $190,750. This represents 0.09% of its overall portfolio holdings.

Number of Shares
48,048
Previous 595,665 91.93%
Holding current value
$190,750
Previous $166,000 34.94%
% of portfolio
0.09%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$0.31 - $3.24 $169,761 - $1.77 Million
-547,617 Reduced 91.93%
48,048 $108,000
Q2 2022

Aug 15, 2022
BUY
$1.97 - $10.0 $1.17 Million - $5.96 Million
595,665 New
595,665 $1.17 Million

Others Institutions Holding SNTI

# of Institutions
3
Shares Held
342K
Call Options Held
0
Put Options Held
0
View Full List

About Senti Biosciences, Inc.

SNTI Quotes by TradingView
  • Ticker SNTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,757,100
  • Market Cap $174M
  • Description
  • Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...
More about SNTI
Track This Portfolio

Track Intel Corp Portfolio

Follow Intel Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Intel Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email